Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Administration of docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte colony-stimulating factor for pretreated non-small cell lung cancer: a phase II study.
Kasahara N, Sunaga N, Kuwako T, Naruse I, Imai H, Jingu A, Tsukagoshi Y, Masuda T, Kitahara S, Tsurumaki H, Yatomi M, Hara K, Koga Y, Sakurai R, Mori K, Kaira K, Maeno T, Asao T, Hisada T. Kasahara N, et al. Among authors: hara k. Support Care Cancer. 2020 Oct;28(10):4825-4831. doi: 10.1007/s00520-020-05317-z. Epub 2020 Jan 25. Support Care Cancer. 2020. PMID: 31982960 Clinical Trial.
Phase I study of oral S-1 plus Cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
Kaira K, Sunaga N, Yanagitani N, Kawata T, Utsugi M, Shimizu K, Ebara T, Kawamura H, Nonaka T, Ishikawa H, Sakurai H, Suga T, Hara K, Hisada T, Ishizuka T, Nakano T, Mori M. Kaira K, et al. Among authors: hara k. Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):109-14. doi: 10.1016/j.ijrobp.2008.06.1938. Epub 2008 Oct 15. Int J Radiat Oncol Biol Phys. 2009. PMID: 18929446 Clinical Trial.
A case of Trousseau syndrome caused by pulmonary adenocarcinoma that was controlled for one year and 10 months with thrombosis treatment using an EGFR tyrosine kinase inhibitor and chemotherapy.
Masubuchi H, Maeno T, Uchida M, Kono S, Suzuki M, Takemura M, Yamaguchi A, Yamaguchi K, Kanbe M, Kitahara S, Hara K, Hara S, Aoki N, Suga T, Kurabayashi M. Masubuchi H, et al. Among authors: hara k, hara s. Respir Med Case Rep. 2015 May 23;15:101-5. doi: 10.1016/j.rmcr.2015.05.001. eCollection 2015. Respir Med Case Rep. 2015. PMID: 26236616 Free PMC article.
Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
Yamaguchi K, Yamaguchi A, Kashiwagi C, Sawada Y, Taguchi K, Umetsu K, Oshima K, Uchida M, Suzuki M, Kono S, Takemura M, Masubuchi H, Kitahara S, Hara K, Maeno T, Motegi SI, Muro Y, Sakairi T, Hisada T, Kurabayashi M. Yamaguchi K, et al. Among authors: hara k. Respir Med. 2018 Jul;140:1-5. doi: 10.1016/j.rmed.2018.05.010. Epub 2018 May 22. Respir Med. 2018. PMID: 29957268 Free article.
Clinical value of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography for interstitial lung disease and myositis in patients with dermatomyositis.
Motegi SI, Fujiwara C, Sekiguchi A, Hara K, Yamaguchi K, Maeno T, Higuchi T, Hirasawa H, Kodaira S, Tomonaga H, Tsushima Y, Ishikawa O. Motegi SI, et al. Among authors: hara k. J Dermatol. 2019 Mar;46(3):213-218. doi: 10.1111/1346-8138.14758. Epub 2019 Jan 4. J Dermatol. 2019. PMID: 30614031
4,236 results